Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $322.19 in the prior trading day, Molina Healthcare Inc (NYSE: MOH) closed at $302.09, down -6.24%. In other words, the price has decreased by -$6.24 from its previous closing price. On the day, 1.11 million shares were traded. MOH stock price reached its highest trading level at $321.525 during the session, while it also had its lowest trading level at $299.65.
Ratios:
Our goal is to gain a better understanding of MOH by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.
On March 05, 2025, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $295 to $372.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when ORLANDO STEVEN J sold 1,000 shares for $301.33 per share. The transaction valued at 301,330 led to the insider holds 17,375 shares of the business.
ORLANDO STEVEN J bought 1,000 shares of MOH for $301,000 on Mar 03 ’25. On Nov 18 ’24, another insider, Schapiro Richard M, who serves as the Director of the company, sold 136 shares for $292.72 each. As a result, the insider received 39,810 and left with 11,556 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 17623748608 and an Enterprise Value of 11002994688. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.79, and their Forward P/E ratio for the next fiscal year is 10.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 0.281 whereas that against EBITDA is 6.029.
Stock Price History:
The Beta on a monthly basis for MOH is 0.66, which has changed by -0.16830021 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $370.99, while it has fallen to a 52-week low of $262.32. The 50-Day Moving Average of the stock is -3.25%, while the 200-Day Moving Average is calculated to be -4.28%.
Shares Statistics:
The stock has traded on average 811.87K shares per day over the past 3-months and 945150 shares per day over the last 10 days, according to various share statistics. A total of 56.00M shares are outstanding, with a floating share count of 53.97M. Insiders hold about 1.33% of the company’s shares, while institutions hold 98.27% stake in the company. Shares short for MOH as of 1743379200 were 1278963 with a Short Ratio of 1.58, compared to 1740700800 on 1719736. Therefore, it implies a Short% of Shares Outstanding of 1278963 and a Short% of Float of 3.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Molina Healthcare Inc (MOH) is presently subject to a detailed evaluation by 14.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $6.2, with high estimates of $6.55 and low estimates of $5.82.
Analysts are recommending an EPS of between $24.76 and $23.67 for the fiscal current year, implying an average EPS of $24.48. EPS for the following year is $28.2, with 14.0 analysts recommending between $31.0 and $27.09.
Revenue Estimates
11 analysts predict $10.81B in revenue for the current quarter. It ranges from a high estimate of $11.36B to a low estimate of $10.37B. As of the current estimate, Molina Healthcare Inc’s year-ago sales were $9.93BFor the next quarter, 11 analysts are estimating revenue of $10.82B. There is a high estimate of $11.31B for the next quarter, whereas the lowest estimate is $10.43B.
A total of 13 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $44.61B, while the lowest revenue estimate was $43.53B, resulting in an average revenue estimate of $44.1B. In the same quarter a year ago, actual revenue was $40.65BBased on 13 analysts’ estimates, the company’s revenue will be $47.53B in the next fiscal year. The high estimate is $48.61B and the low estimate is $46.78B.
